# DESCRIPTION

## FIELD OF THE DISCLOSURE

- define field

## BACKGROUND

- motivate pyroptosis

## BRIEF SUMMARY

- summarize composition

## DETAILED DESCRIPTION

- motivate pyroptosis-mediated cancer immunotherapy
- limitations of pyroptosis-mediated cancer immunotherapy
- describe VNP-GD delivery system for gasdermin D protein
- describe EI-NP for sustained release of ESCRT inhibitor
- describe hydrogel delivery system for VNP-GD and EI-NP
- describe biodegradable nanoparticles for ESCRT inhibitor
- describe methods of treating primary and inoperable tumors

### EXAMPLES

- describe cell and antibody preparation
- synthesize GSH responsive linker
- synthesize and characterize ESCRT inhibitor-loaded dextran nanoparticles
- prepare and characterize protein cage-conjugated bacteria
- characterize VNP-GD induced tumor cell pyroptosis
- perform western blot assay of pyroptosis related signaling pathway
- perform flow cytometry assay of calcium influx and confocal imaging of ESCRT III-mediated cell membrane repair
- prepare and characterize hydrogel-based bacteria delivery system
- evaluate in vivo anti-tumor efficacy and immune activation
- introduce GSH responsive linker
- synthesize protein cages
- characterize VNP-GD-induced tumor cell pyroptosis
- evaluate protein release behavior
- formulate dextran nanoparticle loaded with ESCRT inhibitor
- characterize VNP-GD-induced tumor cell pyroptosis with ESCRT inhibition
- investigate mechanistic study of tumor pyroptosis and ESCRT-dependent cell membrane repair
- evaluate anti-tumor efficacy of VNP-GD+EI-NP in 4T1 metastatic triple-negative breast cancer and B16F10
- investigate tumoral distribution of VNP-GD after peritumoral administration
- evaluate anti-tumor efficacy of VNP-GD/EI-NP@Gel+aPD-1 in 4T1 breast cancer lung metast
- prevent ESCRT-dependent cell membrane repair to enhance pyroptosis and augment anti-tumor immune response

### Discussion

- motivate pyroptosis research
- describe limitations of gasdermin-dependent pyroptosis
- introduce VNP bacteria-based GSDMD protein delivery system
- summarize in vivo anti-tumor treatment efficacy

